PRINCESS MCGRIFF: Open Payments
NPI 1568185320 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,524 in 54 payments from 23 companies in 2025. Trend: 2023 $2,295 · 2024 $2,343 · 2025 $1,524
Food & beverage: $1,439Education: $85
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $240 |
| Janssen Biotech, Inc. | 5 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $207 |
| Medtronic, Inc. | 3 | $165 |
| Procept Biorobotics Corporation | 2 | $132 |
| Astellas Pharma US Inc | 4 | $95 |
| Boston Scientific Corporation | 2 | $71 |
| Ferring Pharmaceuticals Inc. | 1 | $52 |
| Calyxo, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
Products named: ERLEADA, GEMTESA, AQUABEAM ROBOTIC SYSTEM, INTERSTIM, Nubeqa, Xofigo, ORGOVYX, Xtandi.
Industry payments across GA — which companies pay providers there.
